1 (indole-6-carbonyl-D-phenylglycinyl) - 4- (1-methylpiperidin-4-yl) piperazine Dtartrate

Details for Australian Patent Application No. 2005267579 (hide)

Owner Eli Lilly and Company

Inventors Bush, Julie Kay

Agent Spruson & Ferguson

Pub. Number AU-A-2005267579

PCT Pub. Number WO2006/011955

Priority 60/583,599 30.06.04 US

Filing date 13 June 2005

Wipo publication date 2 February 2006

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/454 (2006.01)

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

14 December 2006 PCT application entered the National Phase

  PCT publication WO2006/011955 Priority application(s): WO2006/011955

2 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005267580-Power flow controller responsive to power circulation demand for optimizing power transfer

2005267569-Method for correction of relative objectdetector motion between successive views